Certara Pharmacometrician Receives Faculty Appointment at University of Montreal

PRINCETON, NJ – Aug. 27, 2015 – Certara®, the global biosimulation technology-enabled drug development company, today announced that its Director of Pharmacometrics Samer Mouksassi, PharmD, PhD, FCP, has been appointed an associate professor in the Faculty of Pharmacy at the University of Montreal. In this new role, Dr. Mouksassi will teach clinicians and students how … Continued

Improve Your Approach to Sharing Clinical Trial Data

Transparency and disclosure of clinical trial data has been a hot topic, growing in prominence and strategic discussions over the past few years. Disclosing clinical trial information and creating transparency around clinical trial results are key steps toward increasing trust between the public and the industry. Increased transparency regarding data about ongoing research could spur … Continued

Former Director of Clinical Pharmacology at CDER Joins Certara’s Simcyp Scientific Advisory Board

Dr. Lawrence J. Lesko’s selection underscores biosimulation’s integral role in the drug development process PRINCETON, NJ – Aug. 20, 2015 – Certara®, the global biosimulation technology-enabled drug development company, today announced that Lawrence J. Lesko, PhD, has joined its Simcyp® Scientific Advisory Board (SAB). Dr. Lesko was Director of the Office of Clinical Pharmacology in … Continued

How Pharmacometric Analyses Can Add Value to Oncology Drug Programs

We are standing on the precipice of a new era in oncology drug development. In his Pulitzer prize winning book, The Emperor of All Maladies: A Biography of Cancer, Dr. Siddhartha Mukherjee traces the evolution of the approach to treating cancer. He identifies four major paradigms in our understanding of this disease: Ancient views of … Continued

Certara Head of Simcyp Translational Science Appointed to Xenobiotica Editorial Board

PRINCETON, NJ – Aug. 10, 2015 – Certara®, the global biosimulation technology-enabled drug development company, today announced that Iain Gardner, Ph.D., its senior scientific advisor and head of Simcyp translational science, has been appointed to the Xenobiotica Editorial Board. Dr. Gardner will play an active role in the monthly journal’s peer-review process and help to … Continued